How do I identify the patient from a bone marrow biopsy report?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Identifying the Patient from a Bone Marrow Biopsy Report

A bone marrow biopsy report should always contain patient identification information including the patient's full name, date of birth, medical record number, and a unique specimen identification number to ensure proper patient identification.

Essential Patient Identification Elements

Bone marrow biopsy reports must include several key identifiers to ensure proper patient identification:

Primary Identifiers

  • Patient's full name
  • Date of birth
  • Medical record number (MRN)
  • Unique specimen identification number
  • Collection date and time
  • Ordering physician

Secondary Identifiers

  • Patient's age and gender
  • Hospital/clinic location
  • Ward/department (for inpatients)
  • Date of report generation

Components of a Complete Bone Marrow Report

A properly labeled bone marrow biopsy report should contain:

Header Information

  • Institution name and logo
  • Laboratory accreditation information
  • Report title (e.g., "Bone Marrow Aspiration and Biopsy Report")
  • Patient demographics (as listed above)
  • Specimen details (site, date collected, received)

Clinical Information

  • Relevant clinical history
  • Indication for bone marrow examination
  • Current medications affecting bone marrow
  • Previous relevant diagnoses

Technical Details

  • Biopsy site (typically posterior iliac crest)
  • Quality and adequacy of specimen
  • Processing methods used

Verification Process

To ensure you have the correct patient:

  1. Check for at least two patient identifiers (name and DOB or MRN) 1
  2. Verify that the specimen label matches the report header
  3. Confirm the collection date is appropriate for the clinical context
  4. Check that the ordering physician is correct

Special Considerations

  • For lymphoma staging, ensure the report contains information about infiltration patterns and percentage of involvement 1
  • For myelodysplastic syndromes, verify patient identifiers before reviewing cellularity, blast percentage, and cytogenetic findings 1
  • For multiple myeloma, confirm patient identity before reviewing plasma cell percentage and clonality 2

Common Pitfalls to Avoid

  • Relying on a single identifier: Always check at least two independent identifiers
  • Assuming specimen ownership: Verify patient information even when handed the report directly
  • Overlooking collection date: Ensure the report is current and relevant to present clinical situation
  • Accepting incomplete labeling: Request proper identification if any key elements are missing

Quality Assurance Considerations

  • Reports should follow standardized formats according to institutional and accreditation requirements
  • Patient identifiers should appear on each page of multi-page reports
  • Electronic reports should maintain all identification information in printable format
  • Any amendments to reports should maintain original patient identification

By following these guidelines, you can ensure proper patient identification when reviewing bone marrow biopsy reports, which is critical for appropriate clinical decision-making and patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Multiple Myeloma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.